Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Medford AJ, Carmeli AB, Ritchie A, et al. (2024) A standing platform for cancer drug development using ctDNA-based evidence of recurrence. Nature Reviews. Cancer |
Lloyd MR, Brett JO, Carmeli A, et al. (2024) CDK4/6 Inhibitor Efficacy in -Mutant Metastatic Breast Cancer. Nejm Evidence. 3: EVIDoa2300231 |
Gómez Tejeda Zañudo J, Barroso-Sousa R, Jain E, et al. (2024) Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial. Nature Communications. 15: 2446 |
Fu X, Pereira R, Liu CC, et al. (2023) High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer. Cell Reports. 42: 112821 |
Brett JO, Dubash TD, Johnson GN, et al. (2023) A Gene Panel Associated With Abemaciclib Utility in -Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor Progression. Jco Precision Oncology. 7: e2200532 |
Crowdis J, Balch S, Sterlin L, et al. (2022) A patient-driven clinicogenomic partnership for metastatic prostate cancer. Cell Genomics. 2 |
Barroso-Sousa R, Forman J, Collier K, et al. (2022) Multidimensional Molecular Profiling of Metastatic Triple-Negative Breast Cancer and Immune Checkpoint Inhibitor Benefit. Jco Precision Oncology. 6: e2100413 |
Li Z, McGinn O, Wu Y, et al. (2022) ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. Nature Communications. 13: 2011 |
Li Z, Wu Y, Yates ME, et al. (2022) Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Research |
Qi M, Nayar U, Ludwig LS, et al. (2021) cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries. Bmc Bioinformatics. 22: 611 |